Overview of molecular diagnosis and targeted treatment of tumor

doi:10.3760/cma.j.issn.1673-422X.2015.10.010

Abstract

Abstract: The occurrence and outcome of cancer is related to the involved gene； Detecting the expression of gene in body by the realtime PCR technology can diagnose and evaluate the prognosis of patients early. Through analyzing the abnormal genes and molecular, designing and studying the targeted drugs can achieve the therapeutic effect of "steady, accurate, relentless", at the same time to reduce side effects and to improve the quality of life.

Key words: Neoplasms, Molecular diagnostic techniques, Targeted treatment

Zheng Xiaowen， Wang Yuping， Zhou Yongning. Overview of molecular diagnosis and targeted treatment of tumor[J]. Journal of International Oncology, 2015, 42(10): 756-758.

References

［1］陈运贤. 恶性肿瘤的分子诊断技术［J］. 分子诊断与治疗杂志, 2009, 1(2): 73-76. ［2］李梦菲, 唐秋莎, 陈道桢. 肿瘤靶向治疗的研究进展［J］. 中国医药导报, 2014, 11(25)： 165-168. ［3］邹丹丹, 窦骏. 恶性肿瘤的分子靶点检测和靶向治疗［J］. 临床与实验病理学杂志, 2012, 28(9): 1026-1029. ［4］陈希, 包黎明. 基因组技术在肿瘤分子诊断中的应用［J］. 重庆医科大学学报, 2011, 36(7): 769-771. ［5］ Rushlow DE, Mol BM, Kennett JY, et al. Characterisation of retinoblastomas without rb1 mutations: genomic, gene expression, and clinical studies［J］. Lancet Oncol, 2013, 14(4): 327-334. ［6］齐晓伟, 姜军. Wilms 瘤基因 1 与实体肿瘤发生、演进关系的研究进展［J］. 中华外科杂志, 2013, 51(5): 461-463. ［7］武治国, 陈明清, 董坚, 等. 家族性腺瘤性息肉病——家系调查及 apc 基因胚系突变分析［J］. 国际遗传学杂志, 2010, （2): 117-121. ［8］张淑英, 余志金, 甘爱华, 等. 遗传性非息肉病性结直肠癌遗传易感基因的研究现状［J］. 胃肠病学和肝病学杂志, 2012, 21(11): 989-993. ［9］罗娟娟. Brca1与乳腺癌［J］. 河南医学研究, 2011, 20(3): 382-384. ［10］欧志英, 夏慧敏. MicroRNA在肿瘤分子诊断中的应用［J］. 分子诊断与治疗杂志, 2013, (1): 1-7. ［11］ Cervera P, Fléjou JF. Changing pathology with changing drugs: tumors of the gastrointestinal tract［J］. Pathobiology, 2011, 78(2): 76-89. ［12］樊向荣. 早期胃癌分子诊断及靶向治疗进展［J］. 临床合理用药杂志, 2013, 6(15): 7-8. ［13］薛剑, 娄加陶. 肺癌分子诊断学研究进展［J］. 上海交通大学学报：医学版, 2011, 31（3）: 373-377. ［14］ Tietze R, Lyer S, Durr S, et al. Nanoparticles for cancer therapy using magnetic forces［J］. Nanomedicine(Lond), 2012, 7(3): 447-457. ［15］陈明义, 田京. 超顺磁性氧化铁纳米颗粒在肿瘤靶向治疗中的应用进展［J］. 天津医药, 2013, 41(6): 618-620. ［16］ Maeng JH, Lee DH, Jung KH, et al. Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer［J］. Biomaterials, 2010, 31(18): 4995-5006.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou. Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer [J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun. Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer [J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Yuan Jian, Huang Yanhua. Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer [J]. Journal of International Oncology, 2024, 51(6): 338-343.
[4]	Chen Hongjian, Zhang Suqing. Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients [J]. Journal of International Oncology, 2024, 51(6): 344-349.
[5]	Guo Zehao, Zhang Junwang. Role of PFDN and its subunits in tumorigenesis and tumor development [J]. Journal of International Oncology, 2024, 51(6): 350-353.
[6]	Zhang Baihong, Yue Hongyun. Advances in anti-tumor drugs with new mechanisms of action [J]. Journal of International Oncology, 2024, 51(6): 354-358.
[7]	Xu Fenglin, Wu Gang. Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma [J]. Journal of International Oncology, 2024, 51(6): 359-363.
[8]	Wang Ying, Liu Nan, Guo Bing. Advances of antibody-drug conjugate in the therapy of metastatic breast cancer [J]. Journal of International Oncology, 2024, 51(6): 364-369.
[9]	Zhang Rui, Chu Yanliu. Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota [J]. Journal of International Oncology, 2024, 51(6): 370-375.
[10]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu. Research progress on intestinal flora and non-surgical treatment of the colorectal cancer [J]. Journal of International Oncology, 2024, 51(6): 376-381.
[11]	Liu Jing, Liu Qin, Huang Mei. Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm [J]. Journal of International Oncology, 2024, 51(5): 267-273.
[12]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin. Study on the clinical relationship between inflammatory burden index and gastric cancer [J]. Journal of International Oncology, 2024, 51(5): 274-279.
[13]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao. Effect of cancer nodules on liver metastases after radical resection of colorectal cancer [J]. Journal of International Oncology, 2024, 51(5): 280-285.
[14]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi. Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer [J]. Journal of International Oncology, 2024, 51(5): 286-291.
[15]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying. Research progress of habitat analysis in radiomics of malignant tumors [J]. Journal of International Oncology, 2024, 51(5): 292-297.